ST. CLOUD HOSPITAL
- Type
- Teaching hospital
- Where
- Saint Cloud, MN
- Medicare CCN
- 240036
- Received
- $818,608 in 201 records, 2020 ($27,025 general, $791,583 research)
- Source
- CMS Open Payments search ↗
On this site
- Business registration: St. Cloud Hospital Fuzzy (name and state)
- Business registration: St. Cloud Hospital DBA St. Benedict's Senior Community - Chateau Waters Fuzzy (name and state)
- Nonprofit contractor: St Cloud Hospital Fuzzy (name and state)
- Nonprofit: ST CLOUD HOSPITAL Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2020 | General payment | 14 | $27,025 |
| 2020 | Research payment | 187 | $791,583 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Abbott Laboratories | 23 | $164,217 | 2020 |
| Cardiovascular Systems Inc. | 11 | $129,877 | 2020 |
| Boston Scientific Corporation | 23 | $115,339 | 2020 |
| Amgen Inc. | 9 | $109,250 | 2020 |
| Inari Medical, Inc. | 32 | $89,828 | 2020 |
| Novartis Pharmaceuticals Corporation | 2 | $55,760 | 2020 |
| Medtronic Vascular, Inc. | 15 | $22,410 | 2020 |
| Olympus America Inc. | 1 | $21,352 | 2020 |
| Lexicon Pharmaceuticals, Inc. | 1 | $21,280 | 2020 |
| PFIZER INC. | 21 | $19,700 | 2020 |
| Edwards Lifesciences Corporation | 1 | $19,686 | 2020 |
| Kowa Research Institute, Inc. | 13 | $13,663 | 2020 |
| Medtronic, Inc. | 12 | $12,797 | 2020 |
| Esperion Therapeutics, Inc. | 12 | $5,028 | 2020 |
| SANOFI US SERVICES INC. | 1 | $4,332 | 2020 |
| Pharmacyclics LLC, an AbbVie Company | 8 | $4,155 | 2020 |
| AstraZeneca Pharmaceuticals LP | 1 | $3,390 | 2020 |
| Incyte Corporation | 3 | $3,363 | 2020 |
| Stryker Corporation | 2 | $1,280 | 2020 |
| LEICA MICROSYSTEMS INC. | 7 | $1,261 | 2020 |
| Acerta Pharma LLC | 1 | $440 | 2020 |
| Medline Industries LP | 2 | $195 | 2020 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 187 | $791,583 |
| Education | 1 | $21,352 |
| Grant | 2 | $2,935 |
| Gift | 8 | $2,292 |
| Space rental or facility fees (teaching hospital only) | 1 | $250 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 2 | $195 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | Stryker Corporation | $1,030 | Gift | Cash or cash equivalent | NONE Device, NONE | 2020 | |
| 2020-12-25 | Amgen Inc. | $10,575 | Research payment | Cash or cash equivalent | Repatha Biological, Cardiology | FOURIER OLE (Ph 4) | 2020 |
| 2020-12-22 | Esperion Therapeutics, Inc. | $613 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2020 |
| 2020-12-22 | Esperion Therapeutics, Inc. | $613 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2020 |
| 2020-12-22 | Abbott Laboratories | $375 | Research payment | Cash or cash equivalent | Xience Sierra Coronary Stent System Device, Vascular | XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients | 2020 |
| 2020-12-17 | Edwards Lifesciences Corporation | $19,686 | Research payment | Cash or cash equivalent | Early-TAVR Trial #2016-07 | 2020 | |
| 2020-12-17 | Kowa Research Institute, Inc. | $981 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2020 |
| 2020-12-15 | Pharmacyclics LLC, an AbbVie Company | $165 | Research payment | Cash or cash equivalent | Imbruvica Drug, Oncology | PCYC-1134M-CA | 2020 |
| 2020-12-10 | Cardiovascular Systems Inc. | $715 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2020 |
| 2020-12-09 | Medtronic, Inc. | $2,248 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2020 |
| 2020-12-09 | Medtronic, Inc. | $1,980 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2020 |
| 2020-12-09 | Medtronic, Inc. | $159 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2020 |
| 2020-12-08 | Incyte Corporation | $6 | Research payment | Cash or cash equivalent | Evaluation Of Ruxolitinib And Azacytidine Combination As A Therapy For Patients With Myelofibrosis And Myelodysplastic S | 2020 | |
| 2020-12-07 | Inari Medical, Inc. | $2,919 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | 2020 | |
| 2020-12-02 | PFIZER INC. | $1,750 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-12-02 | PFIZER INC. | $1,750 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-12-02 | PFIZER INC. | $1,750 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-12-02 | PFIZER INC. | $1,750 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-12-02 | PFIZER INC. | $1,750 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-12-02 | PFIZER INC. | $1,750 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-12-01 | Medtronic Vascular, Inc. | $2,750 | Research payment | In-kind items and services | COVID Response Strategies for Hospital and Urgent Care Settings Pilot | 2020 | |
| 2020-12-01 | Esperion Therapeutics, Inc. | $613 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2020 |
| 2020-12-01 | Esperion Therapeutics, Inc. | $613 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2020 |
| 2020-12-01 | Esperion Therapeutics, Inc. | $613 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2020 |
| 2020-12-01 | Esperion Therapeutics, Inc. | $32 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2020 |
| 2020-11-25 | Cardiovascular Systems Inc. | $682 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2020 |
| 2020-11-23 | Amgen Inc. | $6,211 | Research payment | In-kind items and services | Repatha Biological, Cardiology | FOURIER OLE (Ph 4) | 2020 |
| 2020-11-19 | Acerta Pharma LLC | $440 | Research payment | Cash or cash equivalent | CALQUENCE Drug, Oncology | A Randomized, Multicenter, Open-Label, 3 Arm Phase 3 Study of Obinutuzumab in Combination with Chlorambucil, ACP-196 in | 2020 |
| 2020-11-17 | PFIZER INC. | $500 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-11-17 | PFIZER INC. | $500 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-11-16 | Boston Scientific Corporation | $16,202 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | REPRISE IV | 2020 |
| 2020-11-16 | Amgen Inc. | $1,185 | Research payment | In-kind items and services | Repatha Biological, Cardiology | VESALIUS - CV | 2020 |
| 2020-11-12 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-11-12 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-11-12 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-11-12 | Medline Industries LP | $165 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Reprocessed Instruments Medical Supply, Reprocessing | 2020 | |
| 2020-11-11 | Abbott Laboratories | $20,336 | Research payment | Cash or cash equivalent | CardioMEMS HF System Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic-GUIDEd Management of Heart Failure | 2020 |
| 2020-11-10 | Medtronic Vascular, Inc. | $1,000 | Research payment | Cash or cash equivalent | Evera Device, Implantable Cardioverter Defibrillators (ICDs) | Tachy Prediction Download | 2020 |
| 2020-11-05 | Abbott Laboratories | $450 | Research payment | Cash or cash equivalent | Xience Sierra Coronary Stent System Device, Vascular | XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients | 2020 |
| 2020-11-05 | Abbott Laboratories | $100 | Research payment | Cash or cash equivalent | Xience Sierra Coronary Stent System Device, Vascular | XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients | 2020 |
| 2020-11-04 | Abbott Laboratories | $4,498 | Research payment | Cash or cash equivalent | Amplatzer PFO Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER PFO Occluder Post Approval Study | 2020 |
| 2020-11-03 | Kowa Research Institute, Inc. | $1,896 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2020 |
| 2020-11-03 | Esperion Therapeutics, Inc. | $613 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2020 |
| 2020-11-03 | Esperion Therapeutics, Inc. | $245 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2020 |
| 2020-11-03 | Esperion Therapeutics, Inc. | $245 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2020 |
| 2020-11-02 | Boston Scientific Corporation | $3,031 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | HEARTLOGIC INTERVENTION PILOT | 2020 |
| 2020-11-02 | Boston Scientific Corporation | $1,000 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | HEARTLOGIC INTERVENTION PILOT | 2020 |
| 2020-11-02 | Boston Scientific Corporation | $400 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2020 |
| 2020-10-29 | Cardiovascular Systems Inc. | $13,348 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2020 |
| 2020-10-28 | Abbott Laboratories | $4,193 | Research payment | Cash or cash equivalent | Amplatzer Amulet LAAO Device, Vascular | AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial | 2020 |
| 2020-10-19 | Boston Scientific Corporation | $3,532 | Research payment | Cash or cash equivalent | Acuity Device, Tachy | NAVIGATE X4 STUDY | 2020 |
| 2020-10-19 | Boston Scientific Corporation | $1,750 | Research payment | Cash or cash equivalent | Acuity Device, Tachy | NAVIGATE X4 STUDY | 2020 |
| 2020-10-12 | Amgen Inc. | $2,370 | Research payment | In-kind items and services | Repatha Biological, Cardiology | VESALIUS - CV | 2020 |
| 2020-10-07 | Inari Medical, Inc. | $23,643 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-10-07 | Medtronic, Inc. | $500 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2020 |
| 2020-09-30 | Inari Medical, Inc. | $2,893 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-09-30 | Inari Medical, Inc. | $2,568 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-09-30 | Inari Medical, Inc. | $707 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-09-30 | Inari Medical, Inc. | $707 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-09-30 | Inari Medical, Inc. | $707 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-09-30 | Inari Medical, Inc. | $707 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-09-25 | Medtronic, Inc. | $1,983 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2020 |
| 2020-09-25 | Medtronic, Inc. | $675 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2020 |
| 2020-09-25 | Medtronic, Inc. | $527 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2020 |
| 2020-09-24 | Medtronic Vascular, Inc. | $1,035 | Research payment | Cash or cash equivalent | Onyx Device, Liquid Embolics | Onyx ONE Clear | 2020 |
| 2020-09-24 | Kowa Research Institute, Inc. | $997 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2020 |
| 2020-09-22 | Esperion Therapeutics, Inc. | $338 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2020 |
| 2020-09-22 | Esperion Therapeutics, Inc. | $245 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2020 |
| 2020-09-22 | Esperion Therapeutics, Inc. | $245 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2020 |
| 2020-09-21 | Boston Scientific Corporation | $3,153 | Research payment | Cash or cash equivalent | Acuity Device, Tachy | NAVIGATE X4 STUDY | 2020 |
| 2020-08-25 | Lexicon Pharmaceuticals, Inc. | $21,280 | Research payment | Cash or cash equivalent | EFC-14875 | 2020 | |
| 2020-08-25 | Kowa Research Institute, Inc. | $1,092 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2020 |
| 2020-08-20 | Kowa Research Institute, Inc. | $681 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2020 |
| 2020-08-20 | Pharmacyclics LLC, an AbbVie Company | $165 | Research payment | Cash or cash equivalent | Imbruvica Drug, Oncology | PCYC-1134M-CA | 2020 |
| 2020-08-17 | Boston Scientific Corporation | $8,627 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | REPRISE IV | 2020 |
| 2020-08-12 | Abbott Laboratories | $17,621 | Research payment | Cash or cash equivalent | CardioMEMS HF System Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic-GUIDEd Management of Heart Failure | 2020 |
| 2020-08-11 | Medtronic Vascular, Inc. | $1,650 | Research payment | Cash or cash equivalent | Attain Stability Quad | 2020 | |
| 2020-08-07 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-08-07 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-08-05 | Abbott Laboratories | $422 | Research payment | Cash or cash equivalent | Amplatzer PFO Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER PFO Occluder Post Approval Study | 2020 |
| 2020-08-04 | Boston Scientific Corporation | $5,681 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | HEARTLOGIC INTERVENTION PILOT | 2020 |
| 2020-07-29 | Abbott Laboratories | $3,981 | Research payment | Cash or cash equivalent | Amplatzer Amulet LAAO Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial | 2020 |
| 2020-07-28 | Kowa Research Institute, Inc. | $654 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2020 |
| 2020-07-23 | Cardiovascular Systems Inc. | $6,507 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2020 |
| 2020-07-21 | Pharmacyclics LLC, an AbbVie Company | $165 | Research payment | Cash or cash equivalent | Imbruvica Drug, Oncology | PCYC-1134M-CA | 2020 |
| 2020-07-02 | Kowa Research Institute, Inc. | $223 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2020 |
| 2020-06-30 | Inari Medical, Inc. | $2,893 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-06-30 | Inari Medical, Inc. | $2,893 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-06-30 | Inari Medical, Inc. | $2,893 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-06-30 | Inari Medical, Inc. | $2,568 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-06-30 | Inari Medical, Inc. | $2,479 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-06-30 | Inari Medical, Inc. | $707 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-06-28 | PFIZER INC. | $1,000 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-06-28 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-06-28 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-06-28 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-06-28 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-06-25 | Abbott Laboratories | $7,000 | Research payment | Cash or cash equivalent | Amplatzer Amulet LAAO Device, Cardiac Arrhythmias and Heart Failure | Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antago | 2020 |
| 2020-06-25 | Medtronic Vascular, Inc. | $127 | Research payment | Cash or cash equivalent | Onyx Device, Liquid Embolics | Onyx ONE Clear | 2020 |
| 2020-06-16 | Abbott Laboratories | $1,500 | Research payment | Cash or cash equivalent | Xience Sierra Coronary Stent System Device, Vascular | XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients | 2020 |
| 2020-06-16 | Pharmacyclics LLC, an AbbVie Company | $165 | Research payment | Cash or cash equivalent | Imbruvica Drug, Oncology | PCYC-1134M-CA | 2020 |
| 2020-06-16 | Pharmacyclics LLC, an AbbVie Company | $165 | Research payment | Cash or cash equivalent | Imbruvica Drug, Oncology | PCYC-1134M-CA | 2020 |
| 2020-06-12 | Medtronic, Inc. | $1,590 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2020 |
| 2020-06-12 | Medtronic, Inc. | $159 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2020 |
| 2020-06-10 | Medtronic Vascular, Inc. | $2,595 | Grant | In-kind items and services | IN.PACT AV Device, Drug-Coated Balloons | 2020 | |
| 2020-06-08 | Medline Industries LP | $29 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Reprocessed Instruments Medical Supply, Reprocessing | 2020 | |
| 2020-05-20 | Amgen Inc. | $12,517 | Research payment | Cash or cash equivalent | Repatha Biological, Cardiology | VESALIUS - CV | 2020 |
| 2020-05-19 | Olympus America Inc. | $21,352 | Education | In-kind items and services | Ultrasonic Generators Device, Urology/Gynecology | 2020 | |
| 2020-05-18 | Boston Scientific Corporation | $2,513 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | REPRISE IV | 2020 |
| 2020-05-14 | Kowa Research Institute, Inc. | $223 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2020 |
| 2020-05-13 | Abbott Laboratories | $3,731 | Research payment | Cash or cash equivalent | Amplatzer PFO Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER PFO Occluder Post Approval Study | 2020 |
| 2020-05-07 | Cardiovascular Systems Inc. | $40,399 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2020 |
| 2020-05-06 | Abbott Laboratories | $26,149 | Research payment | Cash or cash equivalent | CardioMEMS HF System Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic-GUIDEd Management of Heart Failure | 2020 |
| 2020-05-06 | Medtronic Vascular, Inc. | $596 | Research payment | Cash or cash equivalent | Evera Device, Implantable Cardioverter Defibrillators (ICDs) | Tachy Prediction Download | 2020 |
| 2020-05-04 | Boston Scientific Corporation | $2,994 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | HEARTLOGIC INTERVENTION PILOT | 2020 |
| 2020-04-30 | Abbott Laboratories | $1,000 | Research payment | Cash or cash equivalent | Amplatzer PFO Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER PFO Occluder Post Approval Study | 2020 |
| 2020-04-30 | Cardiovascular Systems Inc. | $617 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2020 |
| 2020-04-28 | Medtronic Vascular, Inc. | $350 | Research payment | Cash or cash equivalent | Onyx Device, Liquid Embolics | Onyx ONE Clear | 2020 |
| 2020-04-24 | Kowa Research Institute, Inc. | $223 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2020 |
| 2020-04-22 | Abbott Laboratories | $8,871 | Research payment | Cash or cash equivalent | Amplatzer Amulet LAAO Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial | 2020 |
| 2020-04-22 | Incyte Corporation | $216 | Research payment | Cash or cash equivalent | Evaluation Of Ruxolitinib And Azacytidine Combination As A Therapy For Patients With Myelofibrosis And Myelodysplastic S | 2020 | |
| 2020-04-20 | Boston Scientific Corporation | $13,084 | Research payment | Cash or cash equivalent | Acuity Device, Tachy | NAVIGATE X4 STUDY | 2020 |
| 2020-04-14 | Medtronic Vascular, Inc. | $750 | Research payment | Cash or cash equivalent | Evera Device, Implantable Cardioverter Defibrillators (ICDs) | Tachy Prediction Download | 2020 |
| 2020-04-14 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-04-14 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-04-09 | Abbott Laboratories | $1,000 | Research payment | Cash or cash equivalent | CardioMEMS HF System Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic-GUIDEd Management of Heart Failure | 2020 |
| 2020-04-09 | Abbott Laboratories | $600 | Research payment | Cash or cash equivalent | CardioMEMS HF System Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic-GUIDEd Management of Heart Failure | 2020 |
| 2020-04-09 | Kowa Research Institute, Inc. | $223 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2020 |
| 2020-04-07 | Medtronic, Inc. | $2,226 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2020 |
| 2020-04-06 | Boston Scientific Corporation | $6,000 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | REPRISE IV | 2020 |
| 2020-04-06 | Boston Scientific Corporation | $3,767 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2020 |
| 2020-04-06 | Boston Scientific Corporation | $2,000 | Research payment | Cash or cash equivalent | Acuity Device, Tachy | NAVIGATE X4 STUDY | 2020 |
| 2020-04-06 | Boston Scientific Corporation | $1,292 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | REPRISE IV | 2020 |
| 2020-04-06 | Boston Scientific Corporation | $1,164 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2020 |
| 2020-04-02 | Abbott Laboratories | $1,500 | Research payment | Cash or cash equivalent | CardioMEMS HF System Device, Cardiac Arrhythmias and Heart Failure | CardioMEMS HF System Post Approval Study | 2020 |
| 2020-04-02 | Cardiovascular Systems Inc. | $975 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2020 |
| 2020-03-31 | Inari Medical, Inc. | $2,893 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-03-31 | Inari Medical, Inc. | $2,893 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-03-31 | Inari Medical, Inc. | $2,893 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-03-31 | Inari Medical, Inc. | $2,479 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-03-31 | Inari Medical, Inc. | $2,479 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-03-31 | Inari Medical, Inc. | $1,926 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-03-31 | Inari Medical, Inc. | $707 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-03-31 | Inari Medical, Inc. | $707 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-03-31 | Inari Medical, Inc. | $707 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-03-31 | Inari Medical, Inc. | $414 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-03-31 | Medtronic Vascular, Inc. | $340 | Grant | In-kind items and services | 2020 | ||
| 2020-03-31 | Abbott Laboratories | $105 | Research payment | In-kind items and services | CardioMEMS HF System Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic-GUIDEd Management of Heart Failure | 2020 |
| 2020-03-24 | Medtronic Vascular, Inc. | $1,926 | Research payment | Cash or cash equivalent | Onyx Device, Liquid Embolics | Onyx ONE Clear | 2020 |
| 2020-03-24 | LEICA MICROSYSTEMS INC. | $67 | Gift | Cash or cash equivalent | N/A Device, CANCER DIAGNOSTICS | 2020 | |
| 2020-03-24 | LEICA MICROSYSTEMS INC. | $67 | Gift | Cash or cash equivalent | N/A Device, CANCER DIAGNOSTICS | 2020 | |
| 2020-03-16 | Boston Scientific Corporation | $1,750 | Research payment | Cash or cash equivalent | EMBLEM Device, TACHY | UNTOUCHED | 2020 |
| 2020-03-16 | Boston Scientific Corporation | $232 | Research payment | Cash or cash equivalent | EMBLEM Device, TACHY | UNTOUCHED | 2020 |
| 2020-03-16 | LEICA MICROSYSTEMS INC. | $195 | Gift | Cash or cash equivalent | N/A Device, CANCER DIAGNOSTICS | 2020 | |
| 2020-03-16 | Boston Scientific Corporation | $165 | Research payment | Cash or cash equivalent | GENERAL - TACHY Device, TACHY | LSS OF 4 SITE | 2020 |
| 2020-03-13 | Medtronic Vascular, Inc. | $3,000 | Research payment | Cash or cash equivalent | CareLink Device, Cardiac Diagnostics and Monitoring | BlueSync | 2020 |
| 2020-03-10 | LEICA MICROSYSTEMS INC. | $287 | Gift | Cash or cash equivalent | N/A Device, CANCER DIAGNOSTICS | 2020 | |
| 2020-03-10 | LEICA MICROSYSTEMS INC. | $278 | Gift | Cash or cash equivalent | N/A Device, CANCER DIAGNOSTICS | 2020 | |
| 2020-03-10 | LEICA MICROSYSTEMS INC. | $278 | Gift | Cash or cash equivalent | N/A Device, CANCER DIAGNOSTICS | 2020 | |
| 2020-03-10 | LEICA MICROSYSTEMS INC. | $86 | Gift | Cash or cash equivalent | N/A Device, CANCER DIAGNOSTICS | 2020 | |
| 2020-03-09 | Pharmacyclics LLC, an AbbVie Company | $3,000 | Research payment | Cash or cash equivalent | Imbruvica Drug, Oncology | PCYC-1134M-CA | 2020 |
| 2020-03-05 | Cardiovascular Systems Inc. | $812 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2020 |
| 2020-03-03 | Inari Medical, Inc. | $364 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-03-02 | Boston Scientific Corporation | $9,474 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | HEARTLOGIC INTERVENTION PILOT | 2020 |
| 2020-02-27 | Medtronic, Inc. | $500 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2020 |
| 2020-02-27 | Medtronic, Inc. | $250 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2020 |
| 2020-02-24 | Kowa Research Institute, Inc. | $5,501 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2020 |
| 2020-02-19 | Abbott Laboratories | $38,823 | Research payment | Cash or cash equivalent | CardioMEMS HF System Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic-GUIDEd Management of Heart Failure | 2020 |
| 2020-02-19 | Boston Scientific Corporation | $26,523 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | REPRISE IV | 2020 |
| 2020-02-13 | Stryker Corporation | $250 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | MAKO Device, KNEES, HIPS | 2020 | |
| 2020-02-12 | Abbott Laboratories | $1,579 | Research payment | Cash or cash equivalent | Amplatzer PFO Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER PFO Occluder Post Approval Study | 2020 |
| 2020-02-12 | Pharmacyclics LLC, an AbbVie Company | $165 | Research payment | Cash or cash equivalent | Imbruvica Drug, Oncology | PCYC-1134M-CA | 2020 |
| 2020-02-12 | Pharmacyclics LLC, an AbbVie Company | $165 | Research payment | Cash or cash equivalent | Imbruvica Drug, Oncology | PCYC-1134M-CA | 2020 |
| 2020-01-31 | Amgen Inc. | $8,923 | Research payment | Cash or cash equivalent | Repatha Biological, Cardiology | VESALIUS - CV | 2020 |
| 2020-01-31 | Medtronic Vascular, Inc. | $2,618 | Research payment | Cash or cash equivalent | Evera Device, Implantable Cardioverter Defibrillators (ICDs) | Tachy Prediction Download | 2020 |
| 2020-01-30 | Amgen Inc. | $4,025 | Research payment | Cash or cash equivalent | Repatha Biological, Cardiology | FOURIER OLE (Ph 4) | 2020 |
| 2020-01-30 | Medtronic Vascular, Inc. | $1,000 | Research payment | Cash or cash equivalent | Onyx Device, Liquid Embolics | Onyx ONE Clear | 2020 |
| 2020-01-23 | Cardiovascular Systems Inc. | $63,381 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2020 |
| 2020-01-23 | Cardiovascular Systems Inc. | $1,527 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2020 |
| 2020-01-22 | Abbott Laboratories | $18,878 | Research payment | Cash or cash equivalent | Amplatzer Amulet LAAO Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial | 2020 |
| 2020-01-22 | Incyte Corporation | $3,141 | Research payment | Cash or cash equivalent | Evaluation Of Ruxolitinib And Azacytidine Combination As A Therapy For Patients With Myelofibrosis And Myelodysplastic S | 2020 | |
| 2020-01-21 | SANOFI US SERVICES INC. | $4,332 | Research payment | Cash or cash equivalent | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotaglif | 2020 | |
| 2020-01-21 | Boston Scientific Corporation | $1,000 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | HEARTLOGIC INTERVENTION PILOT | 2020 |
| 2020-01-21 | Kowa Research Institute, Inc. | $693 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2020 |
| 2020-01-20 | Abbott Laboratories | $1,500 | Research payment | Cash or cash equivalent | Xience Sierra Coronary Stent System Device, Vascular | XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients | 2020 |
| 2020-01-17 | AstraZeneca Pharmaceuticals LP | $3,390 | Research payment | Cash or cash equivalent | IMFINZI Drug, Oncology | A Non-Interventional Primary Data Collection Study to Assess the Prevalence of PD-L1 High in First Line Metastatic and L | 2020 |
| 2020-01-15 | Medtronic Vascular, Inc. | $2,673 | Research payment | Cash or cash equivalent | Onyx Device, Liquid Embolics | Onyx ONE Clear | 2020 |
| 2020-01-15 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2020 |
| 2020-01-14 | Kowa Research Institute, Inc. | $272 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2020 |
| 2020-01-12 | Inari Medical, Inc. | $2,482 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-01-12 | Inari Medical, Inc. | $553 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-01-12 | Inari Medical, Inc. | $414 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-01-12 | Inari Medical, Inc. | $414 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-01-12 | Inari Medical, Inc. | $325 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-01-06 | Amgen Inc. | $18,748 | Research payment | In-kind items and services | Repatha Biological, Cardiology | VESALIUS - CV | 2020 |
| 2020-01-06 | Inari Medical, Inc. | $5,000 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-01-03 | Amgen Inc. | $44,694 | Research payment | In-kind items and services | Repatha Biological, Cardiology | FOURIER OLE (Ph 4) | 2020 |
| 2020-01-03 | Inari Medical, Inc. | $12,894 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2020 |
| 2020-01-02 | Novartis Pharmaceuticals Corporation | $54,710 | Research payment | Cash or cash equivalent | ENTRESTO Drug, CARDIOVASCULAR | PROSPECTIVE COMPARISON OF ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR ARNI VERSUS ACE INHIBITOR TRIAL TO DETERMINE IMPACT | 2020 |
| 2020-01-02 | Novartis Pharmaceuticals Corporation | $1,050 | Research payment | Cash or cash equivalent | ENTRESTO Drug, CARDIOVASCULAR | A MULTICENTER RANDOMIZED DOUBLE BLIND PARALLEL GROUP ACTIVE CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LCZ6 | 2020 |
The latest 200 records of 201.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In St. Cloud, MN, county Stearns County, MN, state Minnesota; placed by its city name.
| Measure | Place (city or town) St. Cloud, MN | County Stearns County, MN | State Minnesota |
|---|---|---|---|
| Population B01003 | 70,629 | 160,865 | 5,739,445 |
| Population, 2020 census P1 | 68,881 | 158,292 | 5,706,494 |
| Median age B01002 | 30.6 | 35.1 | 38.8 |
| Under 18 B01001 | 21.9% | 23.6% | 22.9% |
| 65 and over B01001 | 13.3% | 16.1% | 17.3% |
| Households B11001 | 27,807 | 61,403 | 2,307,955 |
| Foreign born B05002 | 13.5% | 7.9% | 8.7% |
| Median household income B19013 | $61,374 | $77,066 | $89,062 |
| Median family income B19113 | $80,689 | $99,842 | $113,993 |
| Per capita income B19301 | $32,108 | $38,286 | $48,237 |
| Poverty rate B17001 | 20.2% | 12.9% | 9.3% |
| Unemployment rate B23025 | 6.0% | 4.1% | 4.1% |
| Civilian labor force B23025 | 38,559 | 88,499 | 3,119,042 |
| Mean commute (minutes) B08013 | 19.8 | 21.7 | 22.7 |
| Bachelor's degree or higher B15003 | 30.4% | 28.8% | 39.4% |
| Housing units B25001 | 29,762 | 66,625 | 2,545,030 |
| Owner-occupied B25003 | 48.6% | 67.9% | 72.2% |
| Renters B25003 | 51.4% | 32.1% | 27.8% |
| Median home value B25077 | $225,000 | $273,400 | $329,300 |
| Median gross rent B25064 | $1,003 | $1,068 | $1,280 |
| White, not Hispanic B03002 | 64.5% | 80.2% | 75.9% |
| Black B03002 | 19.7% | 9.0% | 6.9% |
| Hispanic or Latino B03002 | 5.8% | 4.8% | 6.4% |
| Asian B03002 | 4.1% | 1.9% | 5.1% |
| American Indian and Alaska Native B03002 | 0.2% | 0.1% | 0.7% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in St. Cloud, MN.
Comments